Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Key Milestones in the Diabetic Neuropathy Market’s Growth Trajectory From 2025 To 2034?
The market size for diabetic neuropathy has expanded significantly in the past few years. Projected growth reads from $5.79 billion in 2024 to $6.21 billion in 2025, with a compound annual growth rate (CAGR) of 7.3%. The increase during the historical period is due to factors such as the global surge in diabetes, improved awareness and diagnostic methods, progress in diabetes management, escalating healthcare spending, and a boost in research and development funding along with patient education drives.
The market size of diabetic neuropathy is predicted to experience swift expansion in the coming years, growing to$9.15 billion in 2029 with a compound annual growth rate (CAGR) of 10.2%. The intense increment during the speculated timeframe can be linked to progress in neuroimaging, patient-driven care models, the broadening scope of clinical trials, an incessant increase in cases of diabetes, precision medicine methodologies, extension of regenerative medicine, and patient-enabling support schemes. The upcoming period is estimated to be governed by trends such as cooperative initiatives in medical exploration, advancements in digital health offerings, state-of-the-art diagnostic technologies, neuroprotective treatments, tailored treatment plans, and the incorporation of artificial intelligence.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9057&type=smp
What Are the Core Market Drivers Propelling Growth in the Diabetic Neuropathy Industry?
The uptick in the incidence of diabetes is set to catalyze the expansion of the diabetic neuropathy market in the future. Diabetes is a chronic condition characterized by the body’s struggle to appropriately manage and store glucose, a form of sugar. Case scenarios arise where the body either fails to yield adequate insulin, a hormone vital to blood sugar control, or simply does not utilize insulin optimally. Diabetic neuropathy refers to a category of nerve damage that can manifest in individuals with diabetes, with diverse types of nerve damage producing different symptoms. For instance, as of August 2022, the IDF Diabetes Atlas report released by the International Diabetes Federation, a Belgium-based worldwide diabetes community and a coalition of over 230 national diabetes associations, reported that 6.7 million deaths in 2021 were due to diabetes. This translates to a diabetes-related death every five seconds. Currently, there are 537 million adults aged between 20–79 living with diabetes which equates to 1 in 10 people. Projections indicate that this figure will rise to 643 million by 2030 and reach 783 million by 2045. Consequently, the escalating incidence of diabetes is fueling the growth of the diabetic neuropathy market.
How Is the Diabetic Neuropathy Market Segmented?
The diabetic neuropathymarket covered in this report is segmented –
1) By Disorder: Peripheral Neuropathy; Autonomic Neuropathy; Proximal Neuropathy; Focal Neuropathy
2) By Drug Class: Analgesics; Anti-Depressants; Anti-Convulsants; Other Drug Classes
3) By Treatment: Drug Treatment; Radiotherapy; Physiotherapy; Other Treatments
4) By Distribution Channel: Online Distribution; Offline Distribution
5) By End-User: Hospitals; Specialty Clinics; Other End-Users
Subsegments:
1) By Peripheral Neuropathy: Distal Symmetric Neuropathy; Mononeuropathy; Polyneuropathy
2) By Autonomic Neuropathy: Cardiovascular Autonomic Neuropathy; Gastrointestinal Autonomic Neuropathy; Genitourinary Autonomic Neuropathy
3) By Proximal Neuropathy: Diabetic Amyotrophy; Lumbosacral Plexus Neuropathy
4) By Focal Neuropathy: Cranial Neuropathy; Cervical Radiculopathy; Other Focal Neuropathies
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=9057&type=smp
Which Regions Are Driving the Next Phase of the Diabetic Neuropathy Market Growth?
North America was the largest region in the diabetic neuropathy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the diabetic neuropathy market during the forecast period. The regions covered in the diabetic neuropathy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Key Market Trends and Innovations Are Shaping the Future of the Diabetic Neuropathy Industry?
Major corporations in the diabetic neuropathy market are pioneering advanced products like the neuromodulation therapy device aimed at broadening treatment alternatives for individuals afflicted with chronic pain caused by diabetic neuropathy. These neuromodulation therapy devices constitute a non-invasive method of treatment that works by manipulating nerve activity to alleviate pain, enhance nerve function, and stimulate healing in patients experiencing diabetic nerve damage. For instance, Neuralace Medical, Inc, an American company specializing in non-drug pain management treatment, gained FDA approval in January 2024 for their Axon Therapy for Chronic Painful Diabetic Neuropathy. The Axon Therapy device is engineered to manage chronic painful diabetic neuropathy (CPDN). This novel therapy uses neuromodulation methods to alleviate pain related to diabetic neuropathy, representing a considerable progression in pain management possibilities for patients diagnosed with this illness. The FDA approval highlights the safety and effectiveness of the device, enabling Neuralace to initiate commercialization and broaden the availability of effective treatment options for those suffering from CPDN.
View the full report here:
https://www.thebusinessresearchcompany.com/report/diabetic-neuropathy-global-market-report
How Is the Diabetic Neuropathy Market Defined and What Are Its Core Parameters?
Diabetic neuropathy is a type of nerve damage that can occur in people with diabetes. High blood sugar levels induce it, which can damage the blood vessels. It can harm various nerves in the body, including those in the feet, organs, and muscles.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9057
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model